Evidence map›Paper›PMID 18579590›Full record

ArticleJournal of virology2008

Magnitude and quality of vaccine-elicited T-cell responses in the control of immunodeficiency virus replication in rhesus monkeys.

Yue Sun, Sampa Santra, Jörn E Schmitz, Mario Roederer, Norman L Letvin

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Intradermal Immunization with rAAV1 Vector Induces Robust Memory CD8Molecular therapy : the journal of the American Society of Gene Therapy · 2017
    Article
  6. Article
  7. Nonhuman primate models for HIV/AIDS vaccine development.Current protocols in immunology · 2013
    Review
  8. Article
  9. Article
  10. Article
  11. SPICE: exploration and analysis of post-cytometric complex multivariate datasets.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2011
    Article
  12. Article
  13. Good cell, bad cell: flow cytometry reveals T-cell subsets important in HIV disease.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2010
    Review
  14. Article
  15. Neonatal innate TLR-mediated responses are distinct from those of adults.Journal of immunology (Baltimore, Md. : 1950) · 2009
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Sang Froid in a time of trouble: is a vaccine against HIV possible?Journal of the International AIDS Society · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Yue SunDepartment of Medicine, Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
Sampa Santra
Jörn E Schmitz
Mario Roederer
Norman L Letvin
Beth Israel Deaconess Medical Center · USNational Institute of Allergy and Infectious Diseases · USHarvard University · US

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
Non-Human Primate CoreZICAI005103 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI FOULDS, KATHRYN · 2009 to 2025
$22.7M
T Cell Dynamics In SIV-infected MacaquesZIAAI005019 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI ROEDERER, MARIO · 2009 to 2014
$3.5M
Intramural NIH HHSNIAID NIH HHS AI060354NIAID NIH HHS N01 AI030033NIAID NIH HHS N01-AI30033NIAID NIH HHS P30 AI060354
6 · The paper itself

Abstract

While a diversity of immunogens that elicit qualitatively different cellular immune responses are being assessed in clinical human immunodeficiency virus vaccine trials, the consequences of those varied responses for viral control remain poorly understood. In the present study, we evaluated the induction of virus-specific T-cell responses in rhesus monkeys using a series of diverse vaccine vectors. We assessed both the magnitude and the functional profile of the virus-specific CD8(+) T cells by measuring gamma interferon, interleukin-2, and tumor necrosis factor alpha production. We found that the different vectors generated virus-specific T-cell responses of different magnitudes and with different functional profiles. Heterologous prime-boost vaccine regimens induced particularly high-frequency virus-specific T-cell responses with polyfunctional repertoires. Yet, immediately after a pathogenic simian-human immunodeficiency virus (SHIV) challenge, no significant differences were observed between these cohorts of vaccinated monkeys in the magnitudes or the functional profiles of their virus-specific CD8(+) T cells. This finding suggests that the high viral load shapes the functional repertoire of the cellular immune response during primary infection. Nevertheless, in all vaccination regimens, higher frequency and more polyfunctional vaccine-elicited virus-specific CD8(+) T-cell responses were associated with better viral control after SHIV challenge. These observations highlight the contributions of both the quality and the magnitude of vaccine-elicited cellular immune responses in the control of immunodeficiency virus replication.

Indexed as

Virus ReplicationAdenoviridaeAnimalsCD8-Positive T-LymphocytesCell CountCohort StudiesCytokinesGenetic VectorsImmunization, SecondaryInterferon-gammaMacaca mulattaRNA, ViralSAIDS VaccinesSimian Immunodeficiency VirusT-LymphocytesTumor Necrosis Factor-alphaCytokinesInterferon-gammaRNA, ViralSAIDS VaccinesTumor Necrosis Factor-alpha

Identifiers

PMID18579590
PMCPMC2519645
OpenAlexW2149984048

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.